Recently, the presence of EPOR signaling and EPO-induced cellular proliferation was confirmed in renal cancer cells (80, 82), head and neck squamous cell carcinomas (77), and cervical cancer cell lines (78), as well as glioma cells (87). This evidence concerns the gene EPO and central nervous system cancer.